[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353390-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353390-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pck2-inhibition-reverses-cisplatin-resistance-of-non-small-cell-lung-cancer-by-triggering-ferroptosis","PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis","","Non-small cell lung cancer (NSCLC) represents about 85% of lung cancers, and platinum-based chemotherapy remains a central treatment but is limited by acquired resistance. Ferroptosis has been linked to chemoresistance; however, the molecular links between metabolic reprogramming and ferroptosis-driven cisplatin resistance in NSCLC are unclear. This study shows PCK2 is upregulated and that its overexpression strengthens ferroptosis resistance and promotes cisplatin chemoresistance. Mechanistically, RGB-286638 free base binds the PCK2 R454 site to activate ferroptosis in cisplatin-resistant cells and restores cisplatin sensitivity in vitro and in vivo, supporting PCK2 targeting as a strategy to improve NSCLC therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pck2-inhibition-reverses-cisplatin-resistance-of-non-small-cell-lung-cancer-by-triggering-ferroptosis/353390/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pck2-inhibition-reverses-cisplatin-resistance-of-non-small-cell-lung-cancer-by-triggering-ferroptosis/353390.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in NSCLC treatment?","Question",{"text":63,"@type":64},"The study addresses cisplatin chemoresistance in NSCLC, which undermines platinum-based chemotherapy effectiveness and contributes to treatment failure and poor outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PCK2 relate to ferroptosis and cisplatin resistance?",{"text":68,"@type":64},"The study reports that PCK2 is significantly upregulated in NSCLC and that PCK2 overexpression enhances ferroptosis resistance, thereby promoting cisplatin chemoresistance.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does RGB-286638 free base play in reversing cisplatin resistance?",{"text":72,"@type":64},"RGB-286638 free base inhibits PCK2 expression by directly binding to its R454 site, activates ferroptosis in cisplatin-resistant cells, and restores cisplatin sensitivity in vitro and in vivo.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353390,1791290395,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","The FASEB Journal  \nRESEARCH ARTICLE  OPEN ACCESS   \nPCK2 Inhibition Reverses Cisplatin Resistance of  \nNon-Small Cell Lung Cancer by Triggering Ferroptosis  \nJing Liu1 | Ziyan Wang1 | Chen Gu2 | Yili Chen1 | Yang Yang1 | Jianjie Zhu1,3 | Yihua Zhang4 | Yuna Shao4 | Xiaodong Pang1 | Yujie Ge1 | Huiwen Qian1 | Jian-an Huang1,3 | Zeyi Liu1,3 | Yuanyuan Zeng1,3  | Cheng Ji5  \n1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China | 2Department of Respiratory Medicine, Taixing Second People's Hospital, Taixing, China | 3Institute of Respiratory Diseases, Soochow University, Suzhou, China | 4Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China | 5Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, The First Affiliated Hospital of Soochow University, Suzhou, China  \nCorrespondence: Yuanyuan Zeng ([yuanyuanzeng@suda.edu.cn](yuanyuanzeng@suda.edu.cn)) | Cheng Ji ([jicheng_suda@163.com](jicheng_suda@163.com))  \nReceived: 15 May 2026 | Revised: 7 July 2026 | Accepted: 5 August 2026  \nKeywords: Cisplatin | Ferroptosis | NSCLC | PCK2 | RGB-286638 free base  \nABSTRACT  \nNon-small cell lung cancer (NSCLC) accounts for ~85% of lung cancers, with platinum-based chemotherapy as the main treatment. Ferroptosis has been implicated in cancer chemoresistance, yet the molecular mechanisms linking metabolic reprogramming to ferroptosis-mediated cisplatin resistance in NSCLC remain elusive. In this study, we found that phosphoenolpyruvate carboxykinase 2 (PCK2), a metabolic reprogramming enzyme, was significantly upregulated, and its overexpression enhanced ferroptosis resistance, thereby promoting cisplatin chemoresistance. Mechanistically, RGB-286638 free base (RGB) inhibits PCK2 expression by directly binding to its R454 site to activate ferroptosis in cisplatin-resistant cells and restores cisplatin sensitivity both in vitro and in vivo. Targeting PCK2 with RGB provides a promising strategy to overcome chemoresistance, facilitating improved clinical interventions for NSCLC.  \n1 | Introduction  \nChemotherapy remains a cornerstone in the clinical management of non-small cell lung cancer (NSCLC), serving as a primary therapeutic strategy for inhibiting tumor progression and improving patient survival [1–3] . However, the acquisition of chemoresistance represents a major impediment to the efficacy of chemotherapeutic agents in NSCLC treatment, often leading to treatment failure, disease recurrence, and poor clinical outcomes. NSCLC cells develop chemoresistance through multifaceted mechanisms, including enhanced drug efflux, activation of anti-apoptotic signaling pathways, dysregulation of DNA  \ndamage repair machinery, and remodeling of the tumor microenvironment [4, 5] . These adaptive alterations enable NSCLC cells to evade the cytotoxic effects of chemotherapeutics, posing a significant challenge to current NSCLC treatment paradigms.  \nFerroptosis, a distinct form of regulated cell death characterized by iron-dependent lipid peroxidation and the disruption of cellular redox homeostasis, has emerged as a promising therapeutic target to overcome tumor chemoresistance [6] . Unlike apoptosis, necrosis, or other cell death modalities, ferroptosis is driven by the accumulation of reactive oxygen species (ROS)-mediated lipid peroxides, which are tightly  \n\n| Abbreviations: CETSA, Cellular thermal shift assay; DARTS, Drug affinity responsive target stability; DDP, Cisplatin; FITC, Fluorescein isothiocyanate; FTH1, Ferritin heavy chain 1; GPX4, Glutathione peroxidase 4; GSH, Glutathione; HE, Hematoxylin–eosin; IHC, Immunohistochemistry; Lipid ROS, Lipid reactive oxygen species; MDA, Malondialdehyde; NSCLC, Non-small cell lung cancer; PCK2, Phosphoenolpyruvate carboxykinase 2; qRT-PCR, Quantitative real-time reverse transcription PCR; RGB, RGB-286638 free base; SLC7A11, Solute carrier family 7 member 11; SPR, Surface plasmon resonance;","cbCainmFB3m7SQov","https://ap.wps.com/l/cbCainmFB3m7SQov","pdf",21503504,18,"English","# Introduction\n## Ferroptosis as a therapeutic target\n# Materials and Methods\n## Cell Culture\n# Results and Discussion\n## Proposed PCK2-RGB-initiated ferroptosis mechanism","[{\"question\":\"What problem does the study address in NSCLC treatment?\",\"answer\":\"The study addresses cisplatin chemoresistance in NSCLC, which undermines platinum-based chemotherapy effectiveness and contributes to treatment failure and poor outcomes.\"},{\"question\":\"How does PCK2 relate to ferroptosis and cisplatin resistance?\",\"answer\":\"The study reports that PCK2 is significantly upregulated in NSCLC and that PCK2 overexpression enhances ferroptosis resistance, thereby promoting cisplatin chemoresistance.\"},{\"question\":\"What role does RGB-286638 free base play in reversing cisplatin resistance?\",\"answer\":\"RGB-286638 free base inhibits PCK2 expression by directly binding to its R454 site, activates ferroptosis in cisplatin-resistant cells, and restores cisplatin sensitivity in vitro and in vivo.\"}]","PCK2 Inhibition Reverses Cisplatin Resistance of Non-Small Cell Lung Cancer by Triggering Ferroptosis | PDF",1790105082,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cb891a27a67bf98aef63da47be321c8.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/261f99cfef6d145273394f30154bacca.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f42287c46591fb163fdfa104913697d.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1d7aa95e4d96aac4a6f2186e163f58c.webp",980,1287]